Saudi Arabia Medical Cannabis Market

Saudi Arabia Medical Cannabis Market Overview:

The Saudi Arabia medical cannabis market size reached USD 343.4 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 639.9 Million by 2033, exhibiting a growth rate (CAGR) of 7.2% during 2025-2033. The market is driven by increasing global research on cannabis-based treatments, growing awareness of alternative therapies for chronic illnesses, and potential regulatory discussions influenced by evolving international policies. Interest in cannabinoid-based pharmaceuticals, particularly for epilepsy and pain management, is rising, further aiding the Saudi Arabia medical cannabis market growth.

Saudi Arabia Medical Cannabis Market Trends:

Evolving Medical Awareness and Research Initiatives

The growing global acceptance of medical cannabis has prompted increased discussions in Saudi Arabia regarding its potential therapeutic applications. While the use of cannabis remains prohibited in the country, there is a noticeable shift toward exploring its medicinal benefits for conditions such as chronic pain, epilepsy, and various neurological disorders. Educational institutions and doctors are calling for more studies to assess its effectiveness and safety. This change is fueled by the wider global movement of incorporating cannabis into medicine and the growing need for alternative medications. The emphasis continues to be on creating a scientific foundation for its application, potentially leading the way for future regulatory debates thus contributing to the Saudi Arabia medical cannabis market outlook.

Potential Policy Reevaluation and Regulatory Discussions

Saudi Arabia’s strict legal stance on cannabis continues to shape the medical cannabis market, but discussions about controlled medical applications are emerging. Some policymakers are evaluating global regulatory frameworks where cannabis has been integrated into healthcare systems. As international trade partners and neighboring nations adapt evolving policies on medical cannabis, there is potential for Saudi Arabia to assess regulated medical access under strict guidelines. This possibility remains largely theoretical, but global market dynamics and increasing medical advocacy may influence future regulatory discourse. Any policy shift would require a comprehensive legal framework addressing distribution, prescription protocols, and medical supervision, ensuring alignment with the country’s healthcare objectives while maintaining compliance with ethical and religious principles.

Growing Interest in Cannabinoid-Based Pharmaceuticals

The growing consciousness about cannabinoid-derived pharmaceuticals across the globe's healthcare systems has generated interest among Saudi Arabia-based medical experts and researchers further leading to the rising Saudi Arabia medical cannabis market share. Though direct access to medical cannabis is not available, pharmaceutical alternatives obtained from cannabinoids, like CBD-derived medications, are becoming more sought after due to their presumed curative powers. These drugs are being thought about for controlling chronic pain, epilepsy, and end-of-life care. International examples of how effectively these treatments can work are informing the debates within Saudi Arabia's health sector. Nonetheless, regulatory clearance and clinical trials continue to be main hindrances to market entry. The potential to introduce cannabinoid-based medicines would depend on wide-ranging clinical research, governmental approval, and confluence with national health policies in order to establish efficacy and safety.

Saudi Arabia Medical Cannabis Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the region level for 2025-2033. Our report has categorized the market based on species, derivatives, application, route of administration and end use.

Species Insights:

• Indica
• Sativa
• Hybrid

The report has provided a detailed breakup and analysis of the market based on the species. This includes indica, sativa, and hybrid.

Derivatives Insights:

• Cannabidiol (CBD)
• Tetrahydrocannabinol (THC)
• Others

A detailed breakup and analysis of the market based on the derivatives have also been provided in the report. This includes cannabidiol (CBD), tetrahydrocannabinol (THC), and others.

Application Insights:

• Cancer
• Arthritis
• Migraine
• Epilepsy
• Others

The report has provided a detailed breakup and analysis of the market based on the application. This includes cancer, arthritis, migraine, epilepsy, and others.

Route of Administration Insights:

• Oral Solutions and Capsules
• Vaporizers
• Topicals
• Others

A detailed breakup and analysis of the market based on the route of administration have also been provided in the report. This includes oral solutions and capsules, vaporizers, topicals, and others.

End Use Insights:

• Pharmaceutical Industry
• Research and Development Centres
• Others

The report has provided a detailed breakup and analysis of the market based on the end use. This includes pharmaceutical industry, research and development centres, and others.

Regional Insights:

• Northern and Central Region
• Western Region
• Eastern Region
• Southern Region

The report has also provided a comprehensive analysis of all the major regional markets, which include Northern and Central, Western, Eastern, and Southern Region.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Saudi Arabia Medical Cannabis Market Report Coverage:

Key Questions Answered in This Report:

• How has the Saudi Arabia medical cannabis market performed so far and how will it perform in the coming years?
• What is the breakup of the Saudi Arabia medical cannabis market on the basis of species?
• What is the breakup of the Saudi Arabia medical cannabis market on the basis of derivative?
• What is the breakup of the Saudi Arabia medical cannabis market on the basis of application?
• What is the breakup of the Saudi Arabia medical cannabis market on the basis of route of administration?
• What is the breakup of the Saudi Arabia medical cannabis market on the basis of end use?
• What is the breakup of the Saudi Arabia medical cannabis market on the basis of region?
• What are the various stages in the value chain of the Saudi Arabia medical cannabis market? 
• What are the key driving factors and challenges in the Saudi Arabia medical cannabis?
• What is the structure of the Saudi Arabia medical cannabis market and who are the key players?
• What is the degree of competition in the Saudi Arabia medical cannabis market? 

Key Benefits for Stakeholders:

• IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the Saudi Arabia medical cannabis market from 2019-2033.
• The research report provides the latest information on the market drivers, challenges, and opportunities in the Saudi Arabia medical cannabis market.
• Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the Saudi Arabia medical cannabis industry and its attractiveness.
• Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.